Tuberculous meningitis in Greek children

Scandinavian Journal of Infectious Diseases

Volumn 44, Issue 5, 2012, Pages 337-343

  Mihailidou, Elissavet ^a   Goutaki, Myrofora ^a   Nanou, Anastasia ^a   Tsiatsiou, Olga ^a   Kavaliotis, John ^a  

^a Infectious Diseases Hospital of Thessaloniki   (Greece)

Author keywords

Hydrocephalus; Meningitis; Tuberculosis

Indexed keywords

CORTICOSTEROID; ETHAMBUTOL; HEMOGLOBIN; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN; STREPTOMYCIN;

ADOLESCENT; ARTICLE; BLOOD CULTURE; CEREBROSPINAL FLUID; CHILD; CHILDHOOD DISEASE; CLINICAL ARTICLE; COMA; CRANIAL NERVE PARALYSIS; DISEASE CLASSIFICATION; ERYTHROCYTE SEDIMENTATION RATE; FAMILY HISTORY; GREECE; HUMAN; HYDROCEPHALUS; INFANT; LEUKOCYTE COUNT; LUNG TUBERCULOSIS; MILIARY TUBERCULOSIS; PRESCHOOL CHILD; SCHOOL CHILD; SEIZURE; SPONDYLITIS; TUBERCULIN TEST; TUBERCULOUS MENINGITIS;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; FEMALE; GREECE; HUMANS; HYDROCEPHALUS; INFANT; MALE; MYCOBACTERIUM TUBERCULOSIS; PROGNOSIS; TUBERCULIN TEST; TUBERCULOSIS, MENINGEAL; TUBERCULOSIS, PULMONARY;

EID: 84859747573     PISSN: 00365548     EISSN: 16511980     Source Type: Journal    
DOI: 10.3109/00365548.2011.639030     Document Type: Article

References (34)

1. World Health Organization (WHO). Global tuberculosis control: Surveillance, planning, fi nancing. WHO report 2007. WHO/HTM/TB/2007.376. Geneva: WHO; 2007.
2. European Centre for Disease Prevention and Control (ECDC)/World Health Organization Regional Offi ce for Europe. Tuberculosis surveillance in Europe 2009. Stockholm: ECDC; 2011. Available at: http://www.ecdc.europa. eu/en/publications/Publications/1103-TB-SUR-2009.pdf (accessed 16 February 2011).
3. World Health Organization (WHO). Greece, TB control country profi le. Global tuberculosis control: Epidemiology, strategy, fi nancing: WHO report 2007. Geneva: WHO; 2007. Available at: http://apps.who.int/globalatlas/predefi nedReports/TB/PDF-Files/grc.pdf (accessed 16 February 2011).
4. Jelastopulu E, Alexopoulos EC, Venieri D, [4] Tsiros G, Komninoy G, Constantinidis TC, et al. Substantial underreporting of tuberculosis in West Greece: Implications for local and national surveillance. Euro Surveill 2009;14 pii: 19152.
5. Rieder HL, Snider De Jr, Cauthen GM. Extrapulmonary tuberculosis in the United States. Am Rev Respir Dis 1990; 141:347-51.
6. US Centers for Disease Control and Prevention (CDC). Extrapulmonary tuberculosis cases and percentages by site of disease: Reporting areas, 2005. Atlanta, GA: CDC; 2005. Available at: http://www.cdc.gov/tb/surv/surv2005/PDF/ table27.pdf (accessed 16 February 2011).
7. Girgis NI, Sultan Y, Farid Z, Mansour MM, Erian MW, Hanna LS, et al. Tuberculosis meningitis, Abbassia Fever Hospital - Naval Medical Research Unit No. 3 - Cairo, Egypt, from 1976 to 1996. Am. J. Trop Med Hyg 1998;58:28-34.
8. Farinha NJ, Razali KA, Holzel H, Morgan G, Novelli VM. Tuberculosis of the central nervous system in children: A 20-year survey. J Infect 2000;41:61-8.
9. Kent SJ, Crowe SM, Yung A, Lucas CR, Mijch AM. Tuberculous meningitis: A 30-year review. Clin Infect Dis 1993;17: 987-94.
10. Thilothammal N, Krishnamurthy PV, Banu K, Ratnam SR. Tuberculous meningitis in children - Clinical profi le, mortality and morbidity of bacteriologically confi rmed cases. Indian Pediatr 1995;32:641-7.
11. Van Well GT, Paes BF, Terwee CB, Springer P, Roord JJ, Donald PR, et al. Twenty years of pediatric tuberculous meningitis: A retrospective cohort study in the western cape of South Africa. Pediatrics 2009;123:e1 - 8.
12. Yaramiş A, Gurkan F, Elevli M, Sök er M, Haspolat K, Kirba G, TaŞ MA. Central nervous system tuberculosis in children: A review of 214 cases. Pediatrics 1998;102:E49.
13. Medical Research Council. Streptomycin in Tuberculosis Trials Committee. Streptomycin treatment of tuberculous meningitis. Lancet 1948;1:582-96.
14. Cruz AT, Starke JR. Clinical manifestations of tuberculosis in children. Paediatr Respir Rev 2007;8:107-17.
15. ATS/CDC Statement Committee on Latent Tuberculosis Infection Membership List. Targeted tuberculin testing and treatment of latent tuberculosis infection. MMWR Morb Mortal Wkly Rep 2000;49:1-51 (RR-6).
16. T runz BB, Fine P, Dye C. Effect of BCG vaccination on childhood tuberculous meningitis and miliary tuberculosis worldwide: A meta-analysis and assessment of cost-effectiveness. Lancet 2006;367:1173-80.
17. Mittal SK, Aggarwal V, Rastogi A, Saini N. Does B.C.G. vaccination prevent or postpone the occurrence of tuberculous meningitis? Indian J Pediatr 1996;63:659-64.
18. Zhang LX, Tu DH, He GX, Ma ZQ, Nagelkerke NJ, Borgdorff MW, et al. Risk of tuberculosis infection and tuberculous meningitis after discontinuation of Bacillus Calmette - Guerin in Beijing. Am. J. Respir Crit Care Med 2000;162: 1314-7.
19. Caudie C, Tholance Y, Quadrio I, Peysson S. [Contribution of CSF analysis to diagnosis and follow-up of tuberculous meningitis] (in French). Ann Biol Clin (Paris) 2010;68:107-11.
20. Yaramis A, Bukte Y, Katar S, Ozbek MN. Chest computerized tomography scan fi ndings in 74 children with tuberculous meningitis in southeastern Turkey. Turk J Pediatr 2007;49:365-9.
21. Theron S, Andronikou S, Grobbelaar M, Steyn F, Mapukata A, du Plessis J. Localized basal meningeal enhancement in tuberculous meningitis. Pediatr Radiol 2006;36:1182-5.
22. Pienaar M, Andronikou S, Van Toorn R. MRI to demonstrate diagnostic features and complications of TBM not seen with CT. Childs Nerv Syst 2009;25:941-7.
23. Janse Van Rensburg P, Andronikou S, Van Toorn R, Pienaar M. Magnetic resonance imaging of miliary tuberculosis of the central nervous system in children with tuberculous meningitis. Pediatr Radiol 2008;38:1306-13.
24. Van Der Merwe DJ, Andronikou S, Van Toorn R, Pienaar M. Brainstem ischemic lesions on MRI in children with tuberculous meningitis: With diffusion weighted confi rmation. Childs Nerv Syst 2009;25:949-54.
25. Van Loenhout-Rooyackers JH, Keyser A, Laheij RJ, Verbeek AL, Van Der Meer JW. Tuberculous meningitis: Is a 6-month treatment regimen suffi cient? Int. J. Tuberc Lung Dis 2001;5:1028-35.
26. Woodfi eld J, Argent A. Evidence behind the WHO guidelines: hospital care for children: What is the most appropriate antimicrobial treatment for tuberculous meningitis? J Trop Pediatr 2008;54:220-4.
27. Nagarathna S, Rafi W, Veenakumari HB, Mani R, Satishchandra P, Chandramuki A. Drug susceptibility profi ling of tuberculous meningitis. Int. J. Tuberc Lung Dis 2008;12:105-7.
28. Thwaites G, Fisher M, Hemingway C, Scott G, Solomon T, Innes J; British Infection Society. British Infection Society guidelines for the diagnosis and treatment of tuberculosis of the central nervous system in adults and children. J Infect 2009;59:167-87.
29. Shamsad IA, Begum T. Initiation of early empiric treatment based on clinical features and early obtainable CSF indices can prevent worse prognosis in childhood meningitis. Mymensingh Med J 2009;18:232-8.
30. Wait JW, Schoeman JF. Behaviour profi les after tuberculous meningitis. J Trop Pediatr 2010;56:166-71.
31. Andronikou S, Wilmshurst J, Hatherill M, VanToorn R. Distribution of brain infarction in children with tuberculous meningitis and correlation with outcome score at 6 months. Pediatr Radiol 2006;36:1289-94.
32. Springer P, Swanevelder S, Van Toorn R, Van Rensburg AJ, Schoeman J. Cerebral infarction and neurodevelopmental outcome in childhood tuberculous meningitis. Eur J Paediatr Neurol 2009;13:343-9.
33. Misra UK, Kalita J, Srivastava M, Mandal SK. Prognosis of tuberculous meningitis: A multivariate analysis. J Neurol Sci 1996;137:57-61.
34. Kalita J, Misra UK. Outcome of tuberculous meningitis at 6 and 12 months: A multiple regression analysis. Int. J. Tuberc Lung Dis 1999;3:261-5.